1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Autoantibodies against methylglyoxal-modified apolipoprotein B100 and apob100 peptide are associated with less coronary artery atherosclerosis and retinopathy in long-term type 1 diabetes
(
- Contribution to journal › Article
- 2020
-
Mark
Reduced oxidized LDL in T2D plaques is associated with a greater statin usage but not with future cardiovascular events
(
- Contribution to journal › Article
- 2019
-
Mark
Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease
(
- Contribution to journal › Article
- 2015
-
Mark
Animal Models of Diabetic Macrovascular Complications: Key Players in the Development of New Therapeutic Approaches.
(
- Contribution to journal › Scientific review
-
Mark
Autoantibodies against basement membrane collagen type IV are associated with myocardial infarction
(
- Contribution to journal › Article
- 2013
-
Mark
Inhibition of nuclear factor of activated T-cells (NFAT) suppresses accelerated atherosclerosis in diabetic mice.
(
- Contribution to journal › Article
- 2012
-
Mark
Increased Inflammation in Atherosclerotic Lesions of Diabetic Akita-LDLr(-/-) Mice Compared to Nondiabetic LDLr(-/-) Mice.
(
- Contribution to journal › Article
- 2009
-
Mark
Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes.
(
- Contribution to journal › Article